cbdMD (YCBD) Income towards Parent Company (2016 - 2025)
cbdMD's (YCBD) quarterly Income towards Parent Company came in at -$283131.0 in Q4 2025, down 1975.66% year-on-year from $15095.0 in Q4 2024, and up 58.36% quarter-over-quarter from -$679968.0 in Q3 2025.
cbdMD (YCBD) Income towards Parent Company (2016 - 2025) Analysis & Trends
cbdMD has disclosed Income towards Parent Company across 10 years of filings, most recently posting -$283131.0 for Q4 2025.
- Income towards Parent Company for Q4 2025 came in at -$283131.0, down 1975.66% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.3 million (up 13.0% YoY), and the FY2025 annual result was -$2.0 million, up 44.84% from the prior year.
- Income towards Parent Company came in at -$283131.0 for Q4 2025 at cbdMD, up from -$679968.0 in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $459737.0 in Q2 2024 to a low of -$31.6 million in Q2 2022.
- The 5-year median for Income towards Parent Company is -$1.3 million (2023), against an average of -$5.8 million.
- Across the five-year window, Income towards Parent Company soared 125.97% in 2024 and plunged 1975.66% in 2025, its largest moves.
- cbdMD's Income towards Parent Company stood at -$19.2 million in 2021, then soared by 79.35% to -$4.0 million in 2022, then soared by 74.81% to -$996501.0 in 2023, then jumped by 101.51% to $15095.0 in 2024, then slumped by 1975.66% to -$283131.0 in 2025.
- The last three Income towards Parent Company figures came in at -$283131.0 (Q4 2025), -$679968.0 (Q3 2025), and -$895272.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | cbdMD | 3,797.57 | -3.38 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -283,131.00 |
| Sep 30, 2025 | -679,968.00 |
| Jun 30, 2025 | -895,272.00 |
| Mar 31, 2025 | -480,757.00 |
| Dec 31, 2024 | 15,095.00 |
| Sep 30, 2024 | -152,799.00 |
| Jun 30, 2024 | 459,737.00 |
| Mar 31, 2024 | -3.01 Mn |
| Dec 31, 2023 | -996,501.00 |
| Sep 30, 2023 | -15.87 Mn |
| Jun 30, 2023 | -1.77 Mn |
| Mar 31, 2023 | -1.34 Mn |
| Dec 31, 2022 | -3.96 Mn |
| Sep 30, 2022 | -14.63 Mn |
| Jun 30, 2022 | -31.63 Mn |
| Mar 31, 2022 | -4.66 Mn |
| Dec 31, 2021 | -19.16 Mn |
| Jun 30, 2020 | -7,781.00 |
| Dec 31, 2019 | -41,202.00 |
| Sep 30, 2019 | -4.11 Mn |